Teva Pharmaceutical Industries (NYSE:TEVA), a global leader in generic and specialty medicines with a market capitalization of $24.93 billion, has been navigating a complex market landscape with a mix ...
Teva announced its intention to divest its active pharmaceutical ingredient business to maximize current and potential revenue streams. Fourth quarter and full year 2023 figures include the impact of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback